Germany· DE-A57-d54558504707059a
Tafluprost/Timolol
A medicinal product containing timolol, tafluprost, registered in Germany by Santen Oy.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Timolol, Tafluprost
- Manufacturer
- Santen Oy
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Timolol, tafluprost in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsTaptiqom 15 microgram/ml + 5 mg/ml oogdruppels, oplossingMedcor Pharmaceuticals B.V.
- CzechiaTAPTIQOMSanten OY, Tampere
- SwedenTafluprost/Timolol Santen 15 mikrogram/ml + 5 mg/ml Ögondroppar, lösning i endosbehållareSanten Oy
- FinlandTafluprost/Timolol SantenSanten Oy
- NorwayTaptiqomSanten Oy
- PolandTaptiqomSanten Oy
- IrelandTaptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose containerPCO Manufacturing Ltd.
- SpainTAPTIQOM 15 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCIONSanten Oy
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Taptiqom
- Belgium · Taptiqom
- Bulgaria · Taptiqom, Таптиком
- Cyprus · Taptiqom
- Czechia · Taptiqom
- Denmark · Tafluprost/Timolol Santen, Taptiqom
- Estonia · Taptiqom, Taptiqom Sine
- Spain · Taptiqom
- Finland · Tafluprost/Timolol Santen, Taptiqom
- France · Taptiqom
- United Kingdom (Northern Ireland) · Taptiqom
- Greece · Taptiqom
- Croatia · Taptiqom
- Hungary · Taptiqom
- Ireland · Taptiqom
- Iceland · Taptiqom, Taptiqom Sine
- Italy · Loyada, Prosoptima
- Lithuania · Taptiqom
- Luxembourg · Taptiqom
- Latvia · Taptiqom
- Malta · Taptiqom
- Netherlands · Taptiqom
- Norway · Taptiqom, Taptiqom Sine
- Poland · Taptiqom, Taptiqom Multi
- Portugal · Taptiqom
- Romania · Taptiqom
- Sweden · Tafluprost/Timolol Santen, Taptiqom
- Slovenia · Taptiqom
- Slovakia · Taptiqom
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/368648ff-7b42-47b5-a647-21ad8040c332 GET /v1/drugs/368648ff-7b42-47b5-a647-21ad8040c332?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Ocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Timolol, Tafluprost",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about timolol, tafluprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.